US Broker Ratings

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 28% Potential Upside with Innovative Biotech Solutions

For investors seeking opportunities in the biotechnology sector, TG Therapeutics, Inc. (NASDAQ: TGTX) presents an intriguing case with its robust market performance and promising pipeline. With..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 10.87% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a prominent player in the healthcare sector, specifically in drug manufacturing, continues to capture investor attention with its strong presence..

STERIS plc (STE) Stock Analysis: Exploring a 10.59% Potential Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may find the current profile of STERIS plc (NYSE: STE) particularly intriguing. With a market capitalization of $23.2 billion,..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating the Healthcare Tech Leader’s Potential Amid Market Volatility

Tempus AI, Inc. (TEM) is carving a niche in the healthcare technology sector with its pioneering integration of advanced analytics and diagnostic services. Headquartered in Chicago,..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Powerhouse with 23.63% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND) is making waves in the biotechnology industry, capturing investor attention with its impressive growth metrics and robust pipeline of therapeutics. Based..

The Cooper Companies, Inc. (COO) Stock Analysis: Strong Buy Ratings with 6.93% Potential Upside

The Cooper Companies, Inc. (NYSE: COO) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Based in San Ramon,..

Becton, Dickinson and Company (BDX) Stock Analysis: Navigating Healthcare with a Strategic Edge

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture investor attention with its diverse portfolio of medical instruments and supplies...

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a 74% Potential Upside in the Vaccine Innovation Leader

Vaxcyte, Inc. (NASDAQ: PCVX), headquartered in San Carlos, California, is garnering significant attention in the biotechnology sector, largely due to its innovative approach to vaccine development...

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 7% Upside Potential in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, continues to capture investor interest..

Danaher Corporation (DHR) Investor Outlook: Strong Buy Ratings and Growth in Healthcare

Danaher Corporation (NYSE: DHR), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, has captured investor attention with its robust market..

DaVita Inc. (DVA) Stock Analysis: Potential 25.66% Upside for Healthcare Investors

DaVita Inc. (DVA) stands as a prominent player in the healthcare sector, specializing in medical care facilities with a focus on kidney dialysis services. Headquartered in..

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Buy Ratings Propel Investor Confidence

Tenet Healthcare Corporation (NYSE: THC) continues to capture investor attention as one of the leading players in the healthcare sector, specifically within the medical care facilities..

Axsome Therapeutics (AXSM) Stock Analysis: Navigating a 37% Potential Upside with Robust CNS Portfolio

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing investor attention with its promising pipeline and robust market position in the biopharmaceutical sector. Focused on developing innovative therapies..

HealthEquity, Inc. (HQY) Stock Analysis: A Potential 12.45% Upside Amid Strong Buy Ratings

Investors seeking opportunities in the healthcare sector might find HealthEquity, Inc. (HQY) an intriguing option, especially given the unanimous buy ratings and a potential upside of..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a Promising 72.76% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA), a key player in the biotechnology sector, is attracting investor attention with its high potential upside of 72.76%. As a biopharmaceutical..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Navigating a 47% Upside Potential Amidst Challenges

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) sits at a critical juncture for investors with a potential upside of 47.3% based on current analyst target averages. As a..

Waystar Holding Corp. (WAY): Analyst Consensus Points to 32.64% Potential Upside

Waystar Holding Corp. (NASDAQ: WAY) is capturing the attention of investors with its promising position in the healthcare sector, specifically within the health information services industry...

Telix Pharmaceuticals (TLX): Investor Outlook on a Biotech Powerhouse with 87% Potential Upside

Telix Pharmaceuticals Limited (TLX) is carving a niche in the innovative field of radiopharmaceuticals, with a specific focus on therapeutic and diagnostic solutions. With an impressive..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and an 18% Upside Potential

Cardinal Health, Inc. (NYSE: CAH) stands out in the healthcare sector, not just for its extensive portfolio of medical and pharmaceutical distribution services but also for..

Globus Medical, Inc. (GMED)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds